
Arkus AI provides AI-powered personalized medicine tools that help healthcare providers and individuals identify and act on genetic and clinical risks. It combines data-driven and knowledge-driven models via an agentic AI platform (Arkus Core) to power intelligent agents for patient engagement, research, and clinical decision support (CDS). The company offers digital tools for healthcare providers alongside an e-health platform for individuals focused on preventive genetic care. Arkus AI has deployed solutions at Karolinska University Hospital and targets clinical and consumer use cases across care, research, and discovery.

Arkus AI provides AI-powered personalized medicine tools that help healthcare providers and individuals identify and act on genetic and clinical risks. It combines data-driven and knowledge-driven models via an agentic AI platform (Arkus Core) to power intelligent agents for patient engagement, research, and clinical decision support (CDS). The company offers digital tools for healthcare providers alongside an e-health platform for individuals focused on preventive genetic care. Arkus AI has deployed solutions at Karolinska University Hospital and targets clinical and consumer use cases across care, research, and discovery.
Headquarters: Stockholm, Sweden
Product: Arkus Core — agentic AI platform for personalised medicine
Focus areas: Genetic diagnostics, clinical decision support, patient engagement
Founders: Ying Cheng; Vladimir Li; Daniel Gillblad
Employees (reported): 8
Personalised medicine and genetic diagnostics for clinical and consumer healthcare use cases.
2020
Hospitals and Health Care
53565
Recorded funding entry with amount and date
“Propel Capital; Sting”
| Company |
|---|